Drug repurposing and discovery represent a transformative approach in modern pharmacology, seeking to identify new therapeutic uses for existing, approved compounds while also uncovering novel drug ...

Move over, Hugh Laurie: there’s a new Dr. House in town. Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model ...

HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...

Mordor Intelligence has published a new report on Drug Repurposing Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction: The drug repurposing market ...

The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...

Glioblastoma, an aggressive brain cancer, has a very poor prognosis. More than 95% of glioblastoma patients die within five years of diagnosis. Glioblastoma has an incidence rate of 3.19 per 100,000 ...

The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...